Anti-infective antibodies are being
used extensively nowadays to treat serious bacterial and viral diseases
such as pneumonia, tuberculosis and malaria. According to the World
Health Organization, six major infectious diseases namely diarrhea,
pneumonia, malaria, acquired immune deficiency syndrome (AIDS) , measles
and tuberculosis are responsible for half of the premature deaths
worldwide killing children and young adults. Moreover, threatening
pandemics such as H1N1 influenza A virus (swine flu) is also adding
pressure on healthcare sector. On the basis of these diseases which are
being treated with the help of anti-infective antibodies, this market is
divided into four major segments namely recombinant antibodies for
viral diseases, recombinant antibodies for bacterial diseases, human
plasma-derived immunoglobulins and Varicella Zoster immunoglobulins
(VZIG). On the basis of disease causing microbe, recombinant antibodies
for viral diseases are further characterized into:
Browse Full Report With TOC: http://www.mrrse.com/analysis/228450
- Respiratory syncytial virus (RSV)
- Hepatitis C virus (HCV)
- Herpes simplex virus
- Influenza virus
- Cytomegalovirus (CMV)
- Hemorrhagic fever viruses
- Rabies virus
- Human immune deficiency virus (HIV)
Similarly, recombinant antibodies for
bacterial diseases are divided into following segments on the basis of
disease causing micro-organisms:
- Bacillus Anthracis
- Pseudomonas
- Staphylococci
- Clostridium Difficile
- Streptococci
- Clostridium Botulinum
Human plasma-derived immunoglobulins
include the antibodies which are derived by human blood plasma
differentiation. On the basis of the different administration method,
the market is divided into five major categories which include:
- Conventional intravenous immunoglobulins (IVIG)
- Injectable SC/IM immunoglobulins
- Enriched immunoglobulins
- Oral immunoglobulins
- Hyperimmunes
Varicella Zoster Immunoglobulins
(VZIG) includes all the anti-infective antibodies which work against the
diseases caused by varicella zoster virus. This segment of the
anti-infective antibodies market is fragmented on the basis of the
immunoglobulins used to treat specific disease conditions which consist
of following categories:
- Tetanus immunoglobulins
- Cytomegalovirus immunoglobulins
- Rabies immunoglobulins
- Hepatitis A immunoglobulins
- Hepatitis B immunoglobulins
- Vaccinia immunoglobulins
To Get Download Full Report with TOC: http://www.mrrse.com/sample/toc/228450
Additionally, the growing emergence of
antibody resistant microorganisms, lethal virus and threat from
engineered microorganisms is stimulating the interest of researchers
towards developing novel anti-infective antibodies. Advances in
understanding the mechanisms and new anti-bodies technologies are also
contributing for the growing class of anti-infective antibodies in
research and development. In anti-infective antibodies market, large
numbers of companies are undergoing clinical trials as for instance,
Novaratis AG is performing Phase IIb clinical trials of Albuferon, drug
for the treatment of hepatitis C and Roche Pharma AG has announced
positive results for PEGASYS combination therapy, treatment for
hepatitis C.
Companies based in North America and
Europe is extensively performing research and development in
anti-infective antibodies segment. The major key players which are
involved in production and research and development in anti-infective
drugs market include Novaratis AG, F. Hoffmann-La Roche Ltd.,
GlaxoSmithKline Plc, Gilead Sciences, Pfizer, Inc., Abbott Laboratories,
Sanofi S.A., Johnson & Johnson and Bristol-Myers Squibb.
This research report analyzes this
market on the basis of its market segments, major geographies, and
current market trends. Geographies analyzed under this research report
include :
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive analysis of :
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of
current trends in the market, industry growth drivers, and restraints.
It provides market projections for the coming years. It includes
analysis of recent developments in technology, Porter’s five force model
analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing
market players and new entrants along with detailed value chain
analysis.
Reasons for Buying this Report:
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
Contact Us
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Toll Free: 866-997-4948
(USA-CANADA)
Tel: +1-518-618-1030
Website: http://www.mrrse.com/
